Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
Standard Induction with Basiliximab versus No-Induction in Low Immunological Risk Kidney Transplant Recipients Prospective Randomized Double Blind Controlled Clinical Trial King Faisal Specialist Hospital and Research Centre Ongoing BASILIXIMAB (SIMULECT) 3 2191177 King Faisal Specialist Hospital and Research Center (Riyadh)
SPIMACO Biosimilar Insulin Phase III Study: Clinical Efficacy and Safety SPIMACO Ongoing Fastulin R / Normulin N 3 N/A (version 1.4) Aug 2011 KFMC
"Somatostatin as inflow modulator in Adult-to-Adult living donor liver transplantation. A randomized, double-blind, placebo-controlled trial" King Faisal Specialist Hospital and Research Centre Ongoing Somatostatin 3 2191109 KFSH & RC-R
Single arm Phase I/II study of the safety, tolerability and efficacy of the Tocilizumab followed by cisplatin/docetaxel in patients with triple negative locally advanced breast cancer King Faisal Specialist Hospital and Research Centre Ongoing TOCILIZUMAB (ACTEMRA) 1/2 2181156 KFSH&RC-R
Single arm Phase I/II study of the safety, tolerability and efficacy of the investigational anti PD-L1 monoclonal antibody Durvalumab in combination with Paclitaxel in patients with metastatic triple negative PD-L1 positive breast cancer AstraZeneca Ongoing Paclitaxel 1, 2 ESR-14-10649 KFSH & RC-R
Safety and Feasibility of CD19 Chimeric Antigen Receptor (CAR) T Cells In Adults with CD19 Positive Relapsed and Refractory Acute Lymphoblastic Leukemia or Lymphoma KAIMRC Completed CD19-CART 1b RC20/446/R NGHA-R
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer SWOG (Southwest Oncology Group) Ongoing CARVEDILOL 3 S1501 KFSH & RC-R
RELATED HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN WITH SYMPTOMATIC SICKLE CELL DISEASE: A PROSPECTIVE STUDY King Faisal Specialist Hospital and Research Centre Ongoing HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) 3 2191237 KFSH&RC-R
Re-EValuating the Inhibition of Stress Erosions and prophylaxis against gastrointestinal bleeding in the critically ill KAIMRC Ongoing pantoprazole 3 CT19/009/R King Abdulaziz Medical City NG (Riyadh)
Re-challenge therapy with chemotherapy and panitumumab in metastatic colorectal cancer patients treated with an anti-EGFR therapy in 1st line treatment: a phase II multicentre study. King Abdullah Medical City, Holy Capital Ongoing PANITUMUMAB 2 19-504 KAMC
View 151 - 160 From 712